Issues

View In: Climate Change

View In: The Case For Medicare For AllProgressives in the U.S. House have the leverage to make demands for both performative gestures and for substantive change. Will they?

View In: The Case For Medicare For AllThese Dems say they aren’t sabotaging their party’s drug pricing plan, but their recent donation hauls suggest otherwise.

View In: The Case For Medicare For AllThree House Dems working to kill drug price legislation raked in roughly $1.6 million from pharma donors — and the top aide for one of them is now a pharma lobbyist.

View In: The Case For Medicare For AllScott Peters, Kurt Schrader, and Kathleen Rice mount weak, incoherent responses trying to explain why they torpedoed a plan to let Medicare negotiate drug prices.

View In: Covid Side EffectsCovid vaccine injuries are being grossly underreported and censored: evidence from multiple, independent sources